论文部分内容阅读
目的分析用脑心通胶囊和敏使朗合用治疗椎基底动脉供血不足患者的疗效。方法将2011年1—12月我院内科门诊椎基底动脉供血不足的112例患者随机分为两组,一组为治疗组,一组为对照组,观察脑心通胶囊和敏使朗合用治疗椎基底动脉供血不足患者的疗效。结果与对照组相比,治疗组56例中治愈的38例(67.86%),有效14例(25.00%),无效4例(7.14%),总有效率(92.86%)。对照组56例中治愈的2例(3.60%),有效12例(21.40%),无效42例(75%),总有效率(25%)。治疗组与对照组治疗效果比较,差异有统计学意义(χ2=63.945,P<0.01)。结论脑心通胶囊和敏使朗合用治疗椎基底动脉供血不足患者有较好疗效。
Objective To analyze the curative effect of Naoxintong capsule and Minileng combined treatment of patients with vertebrobasilar insufficiency. Methods From January to December 2011, 112 patients with insufficiency of vertebrobasilar in medical outpatient department of our hospital were randomly divided into two groups: one was treatment group and the other one was control group. Observation of Naoxintong capsule and Minileng combined treatment Vertebrobasilar insufficiency in patients with curative effect. Results Compared with the control group, 38 cases (67.86%) were cured in 56 cases of treatment group, 14 cases (25.00%) were effective, 4 cases (7.14%) were ineffective, and the total effective rate was 92.86%. In control group, 56 cases were cured in 2 cases (3.60%), effective in 12 cases (21.40%), ineffective in 42 cases (75%) and total effective rate (25%). The treatment group compared with the control group, the difference was statistically significant (χ2 = 63.945, P <0.01). Conclusion Naoxintong Capsule and Minon for the treatment of patients with vertebrobasilar insufficiency have a good effect.